NCT01023685View on ClinicalTrials.gov

To Investigate the Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Alzheimer's Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions
Alzheimer Disease
Interventions
BIOLOGICAL

CAD106

Trial Locations (8)

19102

Drexel University College of Medicine, Philadelphia

33021

Sunrise Clinical Research, Inc., Hollywood

37920

Volunteer Research Group, Knoxville

46202

Indiana University School of Medicine, Indianapolis

60007

Alexian Brothers Neuroscience Institute, Elk Grove Village

75390

University of Texas Southwestern, Dallas

80304

Alpin Research Center, Boulder

92626

ATP Clinical Research, Inc., Costa Mesa

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT01023685 - To Investigate the Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Alzheimer's Patients | Biotech Hunter | Biotech Hunter